rs8193037

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002190.3(IL17A):​c.-121G>A variant causes a upstream gene change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0182 in 1,042,394 control chromosomes in the GnomAD database, including 453 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.017 ( 60 hom., cov: 33)
Exomes 𝑓: 0.018 ( 393 hom. )

Consequence

IL17A
NM_002190.3 upstream_gene

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.188

Publications

41 publications found
Variant links:
Genes affected
IL17A (HGNC:5981): (interleukin 17A) This gene is a member of the IL-17 receptor family which includes five members (IL-17RA-E) and the encoded protein is a proinflammatory cytokine produced by activated T cells. IL-17A-mediated downstream pathways induce the production of inflammatory molecules, chemokines, antimicrobial peptides, and remodeling proteins. The encoded protein elicits crucial impacts on host defense, cell trafficking, immune modulation, and tissue repair, with a key role in the induction of innate immune defenses. This cytokine stimulates non-hematopoietic cells and promotes chemokine production thereby attracting myeloid cells to inflammatory sites. This cytokine also regulates the activities of NF-kappaB and mitogen-activated protein kinases and can stimulate the expression of IL6 and cyclooxygenase-2 (PTGS2/COX-2), as well as enhance the production of nitric oxide (NO). IL-17A plays a pivotal role in various infectious diseases, inflammatory and autoimmune disorders, and cancer. High levels of this cytokine are associated with several chronic inflammatory diseases including rheumatoid arthritis, psoriasis and multiple sclerosis. The lung damage induced by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is to a large extent, a result of the inflammatory response promoted by cytokines such as IL17A. [provided by RefSeq, Sep 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.097 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002190.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL17A
NM_002190.3
MANE Select
c.-121G>A
upstream_gene
N/ANP_002181.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL17A
ENST00000648244.1
MANE Select
c.-121G>A
upstream_gene
N/AENSP00000497968.1

Frequencies

GnomAD3 genomes
AF:
0.0172
AC:
2616
AN:
152082
Hom.:
56
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00725
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0430
Gnomad ASJ
AF:
0.00779
Gnomad EAS
AF:
0.103
Gnomad SAS
AF:
0.00786
Gnomad FIN
AF:
0.0163
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0122
Gnomad OTH
AF:
0.0248
GnomAD4 exome
AF:
0.0184
AC:
16337
AN:
890194
Hom.:
393
AF XY:
0.0176
AC XY:
8120
AN XY:
460724
show subpopulations
African (AFR)
AF:
0.00780
AC:
170
AN:
21808
American (AMR)
AF:
0.0670
AC:
2469
AN:
36878
Ashkenazi Jewish (ASJ)
AF:
0.00863
AC:
175
AN:
20280
East Asian (EAS)
AF:
0.113
AC:
4035
AN:
35608
South Asian (SAS)
AF:
0.00758
AC:
511
AN:
67382
European-Finnish (FIN)
AF:
0.0131
AC:
662
AN:
50348
Middle Eastern (MID)
AF:
0.0245
AC:
111
AN:
4526
European-Non Finnish (NFE)
AF:
0.0121
AC:
7416
AN:
612564
Other (OTH)
AF:
0.0193
AC:
788
AN:
40800
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
731
1462
2194
2925
3656
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
294
588
882
1176
1470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0173
AC:
2627
AN:
152200
Hom.:
60
Cov.:
33
AF XY:
0.0188
AC XY:
1399
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.00727
AC:
302
AN:
41524
American (AMR)
AF:
0.0434
AC:
663
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00779
AC:
27
AN:
3468
East Asian (EAS)
AF:
0.104
AC:
539
AN:
5170
South Asian (SAS)
AF:
0.00766
AC:
37
AN:
4828
European-Finnish (FIN)
AF:
0.0163
AC:
173
AN:
10606
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0122
AC:
830
AN:
67998
Other (OTH)
AF:
0.0246
AC:
52
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
123
246
368
491
614
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0145
Hom.:
47
Bravo
AF:
0.0205
Asia WGS
AF:
0.0600
AC:
207
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
4.4
DANN
Benign
0.91
PhyloP100
-0.19
PromoterAI
-0.016
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8193037; hg19: chr6-52051109; API